Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1179 of 5804
-
AI eye test could catch glaucoma early in underserved communities
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants may have glaucoma, and/or other eye conditions (diabetic retinopathy, cataract, visual acuity impairmen…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis is a first-in-human, Phase I, open-label, multi-center, dose-escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of JMKX005425 in subjects with microsatellite instability-high (MSI) and/or mismatch repair defic…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New pill aims to tame chaotic heartbeats in atrial fibrillation
Disease control Recruiting nowA clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Phase: PHASE2 • Sponsor: Acesion Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New radioactive drug targets FAP-Positive tumors in early trial
Disease control Recruiting nowThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread. Participants must have cancer with high levels of a protein called fibroblast activation protein (FAP). The purpose of this study is to evaluate safety, side effects, and eff…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
At-Home HPV test could boost screening in underserved women
Diagnosis Recruiting nowPhase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening interv…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New asthma drug brenipatide enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up period…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
App + therapy shows promise in cutting suicide risk for eating disorder patients
Prevention Recruiting nowThe purpose of this study is to determine if adding a digital intervention to standard cognitive-behavioral therapy (CBT) is more effective in preventing suicide risk and reducing eating disorder symptoms. Participants will be women between 18 and 65 years old who have recently e…
Phase: NA • Sponsor: Universitat Autonoma de Barcelona • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Fresh produce prescription aims to cut hospital visits for heart failure patients
Disease control Recruiting nowThe purpose of this parallel pragmatic randomized controlled trial (RCT) is to evaluate the impact of Eat Well (an evidence-based 'Food is Medicine' produce prescription program) with varying levels of behavioral support on health outcomes and care utilization patterns of Duke He…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pill could clear psoriasis in weeks
Disease control Recruiting nowA Study to evaluate efficacy and safety in subjects with moderate to severe Plaque Psoriasis treated with a TYK2 Inhibitor for 12 weeks
Phase: NA • Sponsor: Usynova Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Blue dye cream takes on tough skin cancer in new trial
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to evaluate whether formulated methylene blue can safely and effectively treat advanced or inoperable basal cell carcinoma (BCC), a common type of skin cancer. This condition mainly affects adults and often occurs on the head or neck. Some patie…
Phase: PHASE3 • Sponsor: Daryoush Hamidi Alamdari, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could 5 radiation sessions be as good as 30 for skin cancer?
Disease control Recruiting nowThe purpose of this study is to compare the effectiveness and side effects of stereotactic radiotherapy (5 sessions) against conventional (standard) radiotherapy (20-30 sessions) for the treatment of skin cancer involving the head and neck after surgical resection. Stereotactic …
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New vaccine aims to supercharge COVID-19 immunity
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to test two investigational COVID-19 booster vaccines, called CoTend-s3BXBB and CoTend-BXBB, in healthy volunteers ages 40-64. The CoTend-s3BXBB vaccine includes a component called "s3", which was designed to improve the body's response to the v…
Phase: PHASE1, PHASE2 • Sponsor: Kara Chew • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:56 UTC
-
Virtual reality headsets could replace painkillers after hip surgery
Symptom relief Recruiting nowTotal Hip Arthroplasty (THA), a procedure performed to enhance the quality of life, is accompanied by postoperative challenges such as pain and anxiety that adversely affect patient comfort. Inadequate management of these complications can prolong the length of hospital stay, del…
Phase: NA • Sponsor: Adiyaman University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New antibiotic treatment aims to stop infections in breast cancer reconstruction
Prevention Recruiting nowThe researchers are doing this study to find out whether Stimulan Rapid Cure works to reduce the risk of infections in people getting tissue expanders placed during mastectomy. The researchers will also study whether Stimulan Rapid Cure affects the risk of seroma, a possible comp…
Phase: PHASE4 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
New surgical wrap could slash deadly leak risk in rectal cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to learn whether using a reinforcing material called SIS (small intestinal submucosa) during bowel connection after rectal cancer surgery can help prevent anastomotic leakage-a serious complication where the connection between two parts of the i…
Phase: PHASE4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Before surgery, speech lessons for cleft palate babies?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if teaching speech skills to infants with cleft palates, prior to palate repair, will help them to develop speech and language skills. It will also learn about whether the skills are linked to fewer speech sound difficulties when they s…
Phase: NA • Sponsor: Old Dominion University • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New shot aims to slash hidden heart risk in 203 patients
Disease control OngoingThe main purpose of this study is to evaluate the efficacy and safety of HRS-5632 in adult participants with elevated Lipoprotein(a) (Lp(a)) at high risk for cardiovascular events.
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New Needle-Sized device could replace surgery for dialysis access
Disease control Recruiting nowThis study will evaluate the Velocity Percutaneous Arteriovenous Fistula (pAVF) System, a new minimally invasive method for creating dialysis access. People with kidney failure often require dialysis, which depends on having a reliable arteriovenous fistula (AVF). Traditionally, …
Phase: NA • Sponsor: Venova Medical • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with Tough-to-Treat neuroblastoma: experimental drug combo enters human testing
Disease control Recruiting nowBackground: Neuroblastoma is a type of cancer that causes tumors in nerves. It affects mainly infants and toddlers, and it causes about 15 percent of cancer-related deaths in children. Objective: To test a new drug (rhIL-15), combined with 3 standard cancer drugs, in people wi…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New catheter treatment for irregular heartbeat under Long-Term review
Disease control Recruiting nowThe purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC